These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35723593)

  • 61. An Injectable Nanocomposite Hydrogel for Potential Application of Vascularization and Tissue Repair.
    Ding Y; Zhao AS; Liu T; Wang YN; Gao Y; Li JA; Yang P
    Ann Biomed Eng; 2020 May; 48(5):1511-1523. PubMed ID: 32034609
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.
    Qian J; Lu Q; Tao Y; Jiang YR
    Retina; 2011 Jan; 31(1):161-8. PubMed ID: 20890241
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thermo-responsive hydrogel as an anti-VEGF drug delivery system to inhibit retinal angiogenesis in Rex rabbits.
    Hu CC; Chiu YC; Chaw JR; Chen CF; Liu HW
    Technol Health Care; 2019; 27(S1):153-163. PubMed ID: 31045535
    [TBL] [Abstract][Full Text] [Related]  

  • 64. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling.
    Zhu L; Wang W; Xie TH; Zou J; Nie X; Wang X; Zhang MY; Wang ZY; Gu S; Zhuang M; Tan J; Shen C; Dai Y; Yang X; Yao Y; Wei TT
    FASEB J; 2020 Mar; 34(3):4189-4203. PubMed ID: 31957105
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A review of neovascular glaucoma. Etiopathogenesis and treatment.
    Dumbrăveanu L; Cușnir V; Bobescu D
    Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Blood Pressure Is Associated with Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Treatment in Patients with Diabetes.
    Shah AR; Van Horn AN; Verchinina L; Wichorek M; Su L; Markel D; Gardner TW
    Ophthalmol Retina; 2019 May; 3(5):410-416. PubMed ID: 31044732
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR).
    Rao VR; Prescott E; Shelke NB; Trivedi R; Thomas P; Struble C; Gadek T; O'Neill CA; Kompella UB
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5198-204. PubMed ID: 20445119
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
    Joharapurkar A; Patel V; Kshirsagar S; Patel MS; Savsani H; Jain M
    Eur J Pharmacol; 2021 May; 899():174032. PubMed ID: 33753107
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].
    Vorob'eva IV
    Vestn Oftalmol; 2016; 132(5):60-67. PubMed ID: 27911427
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
    Shyong MP; Lee FL; Kuo PC; Wu AC; Cheng HC; Chen SL; Tung TH; Tsao YP
    Mol Vis; 2007 Jan; 13():133-41. PubMed ID: 17293777
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.
    Van Geest RJ; Lesnik-Oberstein SY; Tan HS; Mura M; Goldschmeding R; Van Noorden CJ; Klaassen I; Schlingemann RO
    Br J Ophthalmol; 2012 Apr; 96(4):587-90. PubMed ID: 22289291
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab.
    Matsuyama K; Ogata N; Jo N; Shima C; Matsuoka M; Matsumura M
    Jpn J Ophthalmol; 2009 May; 53(3):243-8. PubMed ID: 19484443
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Monoclonal antibodies in diabetic retinopathy.
    Ebrahimi M; Balibegloo M; Rezaei N
    Expert Rev Clin Immunol; 2022 Feb; 18(2):163-178. PubMed ID: 35105268
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats.
    Paterniti I; Di Paola R; Campolo M; Siracusa R; Cordaro M; Bruschetta G; Tremolada G; Maestroni A; Bandello F; Esposito E; Zerbini G; Cuzzocrea S
    Eur J Pharmacol; 2015 Dec; 769():313-23. PubMed ID: 26607470
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism.
    Gong CY; Yu ZY; Lu B; Yang L; Sheng YC; Fan YM; Ji LL; Wang ZT
    Vascul Pharmacol; 2014 Sep; 62(3):134-42. PubMed ID: 24846859
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy.
    Chung HK; Choi SM; Ahn BO; Kwak HH; Kim JH; Kim WB
    Arzneimittelforschung; 2005; 55(10):573-80. PubMed ID: 16294503
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis.
    Mei X; Zhou L; Zhang T; Lu B; Sheng Y; Ji L
    Vascul Pharmacol; 2018 Feb; 101():29-37. PubMed ID: 29146180
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Study of the influence of angiostatin intravitreal injection on vascular leakage in retina and iris of the experimental diabetic rats.
    Sima J; Ma J; Zhang SX; Guo J
    Yan Ke Xue Bao; 2006 Dec; 22(4):252-8. PubMed ID: 17378159
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy.
    Yokomizo H; Maeda Y; Park K; Clermont AC; Hernandez SL; Fickweiler W; Li Q; Wang CH; Paniagua SM; Simao F; Ishikado A; Sun B; Wu IH; Katagiri S; Pober DM; Tinsley LJ; Avery RL; Feener EP; Kern TS; Keenan HA; Aiello LP; Sun JK; King GL
    Sci Transl Med; 2019 Jul; 11(499):. PubMed ID: 31270273
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of intravitreal bevacizumab on vascular endothelial growth factor expression in patients with proliferative diabetic retinopathy.
    Chung EJ; Kang SJ; Koo JS; Choi YJ; Grossniklaus HE; Koh HJ
    Yonsei Med J; 2011 Jan; 52(1):151-7. PubMed ID: 21155048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.